Financials Filed with SEC as of 08/30/12:
Total Current Assets: $42,167,000
Total Current Liabilities: $21,541,000
Results in Working Capital of $20,616,000: (WOW almost 2:1 ratio)
Long Term Debt: $13,000 (Can that be considered having debt?)
Cash on Hand: $23,749,000 (Is that a pocket change?)
No Inventory: (Nothing to sink the company)
Full Time Employees: 36 (Very small team by today’s standards)
CEO: (60 year old PHD who is compensated modestly)
Six Products in Pipeline:
One in Phase 3 working on FDA approval
Three in Phase2
Two in Preclinical
Guys … this PPS is grossly undervalued.
Right now the share should be trading at least over $9.00.
Although I sound like another pumper … do your own research and decide yourself, the numbers right in yahoo.
Sentiment: Strong Buy